Patents by Inventor Berengere de Laval

Berengere de Laval has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140051631
    Abstract: The present invention relates to a new use of TPO or a TPO/mpl receptor agonist as an adjuvant of a treatment of a neoplastic disease by irradiation or chemotherapeutic agents in order to prevent genomic instability of hematopoietic stem cells incurred through radio- or chemotherapy and hence to prevent the occurrence of secondary cancers, namely acute myelogenous leukemia and myelodisplasia.
    Type: Application
    Filed: August 17, 2012
    Publication date: February 20, 2014
    Inventors: Francoise Porteu, Patrycja Pawlikowska, Berengere de Laval